1. Taiwan Stocks

  2. •

    Electronic technology

  3. •

    Computer peripherals
Diva Laboratories, Ltd.

Diva Laboratories, Ltd.

TTPEX:4153
30.90
TWD
+0.45
(+1.48%)
1.76BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
29.59
30.9
37.44
27.11
20.88
10.79
9.94
11.09
12.14
16.18
15.24
14.7
14.81
- -
Basic EPS, GAAP
2.49
4.1
4.19
-2.34
-6.51
0.87
0.78
0.26
0.37
0.85
1.25
1.6
1.54
- -
Free Cash Flow per Basic Share
2.48
-0.39
4.8
-2.15
0.56
1.03
0.55
-0.58
-0.41
1.05
4.18
2.06
0.34
- -
Dividend per Share
0.4
1.49
2.27
3.12
- -
- -
1.48
- -
0.26
0.37
1
1.25
2
- -
Book Value per Share
13.67
17.12
28.03
23.39
17.9
19.7
18.86
16.86
16.81
17.32
17.6
17.99
17.54
16.49
Tangible Book Value per Share
13.65
16.64
20.42
20.33
17.39
19.42
18.6
16.65
16.65
17.3
17.59
17.96
17.53
16.47
Basic Weighted Avg Shares
26
30
36
37
41
60
72
66
59
59
59
59
59
59
Sales/Revenue/Turnover
777
936
1,344
1,005
857
650
716
737
712
949
894
862
869
- -
Operating Margin (%)
8.32
12.95
9.25
4.92
-5.06
6.99
9.18
9.36
3.36
9.04
10.81
11.89
12.59
- -
Depreciation Expense
12
13
43
48
21
21
19
19
14
10
9
11
10
- -
Net Income, GAAP
65
124
150
-87
-267
52
56
17
22
50
74
94
91
- -
Effective Tax Rate (%)
11.76
17.29
16.2
- -
- -
12.06
14.38
36.79
23.23
26.58
16.12
19.22
16.74
- -
Profit Margin (%)
8.41
13.27
11.19
-8.65
-31.17
8.02
7.83
2.36
3.07
5.23
8.24
10.86
10.42
- -
Working Capital
302
204
778
569
472
865
813
669
682
742
753
784
761
703
LT Debt
188
- -
288
- -
- -
- -
- -
- -
- -
- -
5
3
- -
- -
Total Equity
376
479
1,037
963
807
1,184
1,133
989
986
1,016
1,033
1,056
1,029
967
Return on Invested Capital (%)
11.95
16.61
9.65
- -
- -
3.73
4.89
3.98
1.96
4.11
7.34
8.39
7.95
- -
Return on Capital (%)
13.94
20.99
14.74
- -
- -
4.95
4.84
1.64
2.22
4.97
7.19
8.93
8.67
- -
Return on Common Equity (%)
21.49
29.06
19.84
-8.69
-30.18
5.24
4.84
1.64
2.21
4.96
7.19
8.97
8.69
- -

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
3
2
1
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
59
59
59
Market Capitalization
2,048
1,913
1,760

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
1,084
1,117
1,201
Cash, Cash Equivalents & STI
494
476
549
Accounts Receivable, Net
285
301
312
Inventories
250
305
307
Total Current Liabilities
323
446
497
Payables & Accruals
- -
- -
- -
ST Debt
3
2
1
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.05%
0.82%
-2.5%
Free Cash Flow
-56.89%
-45.81%
-83.66%
Net Income, GAAP
9.36%
44.97%
-3.33%
Sales/Revenue/Turnover
-2.97%
4.26%
0.76%
Total Cash Common Dividend
- -
- -
60%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
222
223
194
223
862
2025
207
235
- -
230
869
2026
223
245
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.42
0.52
0.26
0.4
1.6
2025
0.42
0.44
- -
0.51
1.54
2026
0.42
0.53
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.25
2025
- -
- -
- -
- -
2
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kuo Sen Chen
Full Time Employees
154
Sector
Electronic technology
Industry
Computer peripherals
Address
No. 351, Zhongshan Rd. New Taipei TP Taiwan 235602
IPO Date
Oct 11, 2010
Website
diva.com.tw
Similar Companies
Sandisk Corporation (NASDAQ:SNDK)
Western Digital Corporation (NASDAQ:WDC)
Seagate Technology Holdings PLC (NASDAQ:STX)
Arista Networks, Inc. (NYSE:ANET)
Everpure, Inc. (NYSE:P)
NetApp, Inc. (NASDAQ:NTAP)
Business
DIVA Laboratories, Ltd. (4153.TWO) engages in the development, manufacture, and sale of precision displays and related medical equipment worldwide. The company offers endo/surgical displays providing static and dynamic images for hybrid and integrated operating rooms and control room applications; color and monochrome displays for radiology and medical imaging; touch displays and human-machine interface products; medical and industrial cases; customized display solutions including large-size 4K surgical displays and OLED-integrated panels for real-time ultrasound imaging; and video solutions to original design manufacturers and original equipment manufacturers. DIVA Laboratories also provides displays for picture archiving and communication systems, TFT-LCD for special applications, and embedded display technologies for medical equipment. Incorporated in 1995 and headquartered in New Taipei City, Taiwan, the company operates primarily in the medical display and industrial display segments, serving healthcare providers, radiology applications, and OEM customers globally. Recent developments include winning Royal Philips' Global Supplier Innovation Award and Top 20 Strategic Partner recognition from over 4,500 suppliers for its 30 years of innovation; showcasing large-size 4K surgical displays at COMPUTEX 2025 emphasizing AI healthcare display solutions; exhibiting embedded medical display technologies at Embedded World 2024; and successfully integrating OLED panels into ultrasound systems with proprietary image control technologies to address burn-in and lifespan challenges.